Showing results (41-50 of 588) with videos related to

Sort By:
Pageof 59
Critical Reviews in Oncology/Hematology|May 17, 2019
Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Critical Reviews in Oncology/Hematology|October 26, 2017
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?Ilaria Attili, Antonio Passaro, Alberto Pavan, et al.
Critical Reviews in Oncology/Hematology|May 5, 2025
Evolving treatment for advanced non-small cell lung cancer harbouring common EGFR activating mutationsIgor Gomez-Randulfe, Federico Monaca, David Planchard, et al.
Oncotarget|March 3, 2016
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationValentina Polo, Giulia Pasello, Stefano Frega, et al.
International Journal of Molecular Sciences|April 19, 2019
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung CancerLaura Bonanno, Elisabetta Zulato, Alberto Pavan, et al.
Patient Safety in Surgery|July 2, 2025
Risk factors for 30-day unplanned readmissions after surgical procedures in the elderly populationGino Sartor, Marco Fusco, Marzio Milana, et al.
Cancers|November 13, 2025
Investigating the Trajectories of Association Between Biomarkers and Cancer-Related Cognitive Impairment in Patients with Breast Cancer: A Systematic ReviewAngela Boschetti, Laura Danesin, Elisa Bevilacqua, et al.
Frontiers in Oncology|October 25, 2021
The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the LiteratureGiovanna Garufi, Luisa Carbognin, Armando Orlandi, et al.
Expert Opinion on Drug Safety|April 2, 2014
Targeting the epidermal growth factor receptor in solid tumors: focus on safetyEleonora Lucchini, Sara Pilotto, Elisa Spada, et al.
Annals of Translational Medicine|February 7, 2017
MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapySara Pilotto, Anastasios Gkountakos, Luisa Carbognin, et al.
Pageof 59